The pharmaceutical and medical device industry has never faced greater scrutiny. Regulators are demanding more transparency. Patients are demanding more safety. And companies are under pressure to deliver faster, smarter, and with zero tolerance for compliance failure.
Three capabilities now define the difference between companies that thrive and those that struggle — excellence in clinical research and pharmacovigilance, access to the best medical device consulting services, and the protection that comes from partnering with a provider of the best redaction services.
Krystelis delivers all three — making clinical research crystal clear for pharma and biotech companies worldwide.
Clinical Research and Pharmacovigilance — Safety That Never Sleeps
Patient safety is not a milestone you reach — it is a commitment you maintain every single day. In modern drug development, clinical research and pharmacovigilance work together as a continuous, interconnected cycle. Clinical research generates the evidence needed to bring therapies to patients. Pharmacovigilance ensures those therapies remain safe long after they reach the market.
Krystelis recognises the critical importance of monitoring and managing the safety of pharmaceutical products throughout their lifecycle. Their comprehensive pharmacovigilance services help pharmaceutical companies ensure patient safety, comply with global regulatory requirements, and maintain the integrity of their products — offering end-to-end support from adverse event case management to risk assessment and regulatory reporting, with a proactive and customised approach that ensures potential safety issues are identified and managed effectively.
A world-class clinical research and pharmacovigilance programme covers every dimension of product safety. This includes individual case safety report (ICSR) processing and submission, medical literature monitoring through regular surveillance of global and local databases to identify emerging safety signals, risk management plans (RMPs), benefit-risk assessments, aggregate safety reporting including PSURs and PBRERs, signal detection and evaluation using appropriate data analytics, and pharmacovigilance audits with inspection readiness support through mock audits and gap analysis.
What separates good pharmacovigilance from great pharmacovigilance is a proactive mindset — identifying risks before they escalate, staying ahead of evolving global regulations, and maintaining the kind of rigorous quality assurance that regulators and patients expect. Partnering with Krystelis ensures robust safety monitoring, effective risk management, and compliance with FDA, EMA, and MHRA requirements — allowing pharmaceutical companies to focus on their core mission of developing life-saving therapies.
Best Medical Device Consulting Services — Your Fastest Route to Market
Bringing a medical device to market is one of the most regulated and demanding journeys in healthcare. The tightening of EU MDR 2017/745, evolving FDA 510(k) and PMA pathways, and increasingly rigorous ISO 13485 quality management requirements have raised the bar significantly for device manufacturers worldwide.
For companies that want to succeed, the best medical device consulting services are not a luxury — they are the foundation of every successful device programme.
Krystelis offers comprehensive medical device consulting services to support pharmaceutical and medical device companies in navigating complex regulatory environments, providing end-to-end assistance and ensuring compliance with global regulations from product conception through post-market surveillance.
Services cover regulatory compliance including establishment registration, premarket notification 510(k) and premarket approval (PMA), investigational device exemption (IDE), medical device reporting, and ISO 13485 certification support — alongside customised regulatory strategy development, preparation of technical files, device master files, design dossiers, and design history files.
Medical writing for devices spans clinical evaluation plans, clinical evaluation reports, investigator brochures, instructions for use, periodic safety update reports, and summaries of safety and clinical performance — with post-marketing support covering post-approval changes management, labelling compliance, device registration, and complaints management.
With deep expertise across FDA, EMA, and global regulatory frameworks, Krystelis consistently delivers the best medical device consulting services — accelerating your path to market while protecting patient safety at every step.
Best Redaction Services — Protecting Data, Preserving Science
Transparency in clinical research is a legal obligation and a moral responsibility. But transparency without careful data protection is a serious risk — to patients whose personal information could be exposed, and to companies whose commercially sensitive data could be compromised.
Regulatory authorities including the EMA, FDA, and Health Canada require clinical trial sponsors to make clinical trial documents publicly available. These documents may contain protected personal data (PPD) that could identify individuals, as well as commercially confidential information (CCI). Sponsors must anonymise PPD and CCI to reduce the risk of participant identification and protect CCI — while achieving this without reducing the scientific utility or value of the documents.
This is the defining challenge of the best redaction services — balancing complete transparency with complete data protection. It is a specialist science that demands experience, precision, and deep regulatory knowledge.
Krystelis subject matter experts have been working in this area since 2012, supporting redaction and anonymisation activities for sponsors ranging from small biotechs to top-10 pharmaceutical companies — offering comprehensive end-to-end services covering source document assessment, re-identification risk assessment, anonymisation planning, PPD and CCI redaction, justification tables, and full anonymisation report preparation.
Krystelis has prepared redacted packages under EMA Policies 0043 and 0070, HC PRCI, PMDA, and BfArM — with deep experience liaising with regulators for consultation and comment resolution, and insights gained from contributions to industry forums including DIA, PHUSE, and Informa Connect.
Frequently Asked Questions
Q1. What is the difference between clinical research and pharmacovigilance? Clinical research is the scientific investigation of new therapies in human subjects. Pharmacovigilance is the ongoing monitoring of medicine safety after approval. Together, clinical research and pharmacovigilance form a continuous safety cycle — from first-in-human studies through post-market surveillance — ensuring patient protection at every stage.
Q2. Why do I need the best medical device consulting services rather than handling submissions in-house? Medical device regulations are complex, jurisdiction-specific, and constantly evolving. The best medical device consulting services bring specialist expertise across 510(k), PMA, ISO 13485, and EU MDR pathways simultaneously — reducing the risk of delays, rejections, and costly compliance failures that in-house teams may not be equipped to prevent.
Q3. What documents typically require the best redaction services? Any clinical document destined for public release requires careful redaction — including clinical study reports, protocols, statistical analysis plans, investigator brochures, and device regulatory submissions. The best redaction services ensure PPD and CCI are systematically identified, removed, and justified before disclosure, protecting patients and companies alike.
Q4. Can Krystelis deliver all three services as a single partner? Absolutely. Krystelis is uniquely positioned to deliver world-class clinical research and pharmacovigilance services, the best medical device consulting services, and the best redaction services under one expert roof — eliminating vendor complexity and ensuring consistency of quality, regulatory knowledge, and client collaboration across every engagement.
Conclusion
Excellence in clinical research and pharmacovigilance, the best medical device consulting services, and the best redaction services are no longer optional extras in pharmaceutical and device development. They are the three pillars of a compliant, patient-centric, and commercially successful organisation.
Krystelis delivers all three — with precision, expertise, and an unwavering commitment to making clinical research crystal clear.
Sign in to leave a comment.